Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klapper

Showing results (931-940 of 1,153) with videos related to

Pageof 116
Sort By:
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Journal of Clinical Pathology|September 17, 2008
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)D de Jong, W Xie, A Rosenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker ConsortiumDaphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, et al.
British Journal of Haematology|June 27, 2014
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
The Lancet. Infectious Diseases|March 31, 2023
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational studyDavid W Eyre, Matthias Futschik, Sarah Tunkel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2022
Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 casesEmily M Eichenberger, Amanda C Coniglio, Carmelo Milano, et al.
The New England Journal of Medicine|October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular LymphomaRobert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Genes, Chromosomes & Cancer|October 18, 2012
High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomasItziar Salaverria, Idoia Martin-Guerrero, Birgit Burkhardt, et al.
Diagnostic Microbiology and Infectious Disease|October 31, 2024
Comparative evaluation of swabbing sites for Omicron variant detection in PCR testingTom Fowler, Edward Blandford, David Chapman, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Pageof 116

Showing results (931-940 of 1,153) with videos related to

Sort By:
Pageof 116
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Journal of Clinical Pathology|September 17, 2008
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)D de Jong, W Xie, A Rosenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker ConsortiumDaphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, et al.
British Journal of Haematology|June 27, 2014
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
The Lancet. Infectious Diseases|March 31, 2023
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational studyDavid W Eyre, Matthias Futschik, Sarah Tunkel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 23, 2022
Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 casesEmily M Eichenberger, Amanda C Coniglio, Carmelo Milano, et al.
The New England Journal of Medicine|October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular LymphomaRobert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Genes, Chromosomes & Cancer|October 18, 2012
High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomasItziar Salaverria, Idoia Martin-Guerrero, Birgit Burkhardt, et al.
Diagnostic Microbiology and Infectious Disease|October 31, 2024
Comparative evaluation of swabbing sites for Omicron variant detection in PCR testingTom Fowler, Edward Blandford, David Chapman, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Pageof 116